# Natural Health Trends Corp: financial statements, quarterly

NHTC · Nasdaq · CIK 912061 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nhtc.md) · [Financials](/companies/nhtc/financials.md) · [Filings](/companies/nhtc/filings.md) · [Insiders](/companies/nhtc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nhtc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [10.9 d](/filings/0001437749-25-004700.md) | [11.0](/filings/0001437749-25-013645.md) | [10.5](/filings/0001437749-25-023873.md) | [10.7](/filings/0001437749-25-033153.md) | [10.8 d](/filings/0001437749-26-004876.md) | [10.7](/filings/0001437749-26-013744.md) | [9.8](/filings/0001437749-26-024770.md) | [9.5](/filings/0001437749-26-033713.md) | [9.7 d](/filings/0001437749-26-004876.md) | [9.2](/filings/0001437749-26-013744.md) | [7.6](/filings/0001437749-26-024770.md) | [7.6](/filings/0001437749-26-033713.md) |
| Cost of revenue | $m | [2.8 d](/filings/0001437749-25-004700.md) | [2.9](/filings/0001437749-25-013645.md) | [2.7](/filings/0001437749-25-023873.md) | [2.8](/filings/0001437749-25-033153.md) | [2.8 d](/filings/0001437749-26-004876.md) | [2.8](/filings/0001437749-26-013744.md) | [2.6](/filings/0001437749-26-024770.md) | [2.5](/filings/0001437749-26-033713.md) | [2.6 d](/filings/0001437749-26-004876.md) | [2.3](/filings/0001437749-26-013744.md) | [1.9](/filings/0001437749-26-024770.md) | [2.0](/filings/0001437749-26-033713.md) |
| Gross profit | $m | [8.1 d](/filings/0001437749-25-004700.md) | [8.0](/filings/0001437749-25-013645.md) | [7.8](/filings/0001437749-25-023873.md) | [7.9](/filings/0001437749-25-033153.md) | [8.0 d](/filings/0001437749-26-004876.md) | [7.9](/filings/0001437749-26-013744.md) | [7.3](/filings/0001437749-26-024770.md) | [7.0](/filings/0001437749-26-033713.md) | [7.1 d](/filings/0001437749-26-004876.md) | [6.9](/filings/0001437749-26-013744.md) | [5.7](/filings/0001437749-26-024770.md) | [5.6](/filings/0001437749-26-033713.md) |
| Selling, general and administrative | $m | [3.8 d](/filings/0001437749-25-004700.md) | [3.9](/filings/0001437749-25-013645.md) | [3.8](/filings/0001437749-25-023873.md) | [3.9](/filings/0001437749-25-033153.md) | [3.9 d](/filings/0001437749-26-004876.md) | [3.8](/filings/0001437749-26-013744.md) | [3.6](/filings/0001437749-26-024770.md) | [3.6](/filings/0001437749-26-033713.md) | [3.8 d](/filings/0001437749-26-004876.md) | [3.5](/filings/0001437749-26-013744.md) | [3.3](/filings/0001437749-26-024770.md) | [3.2](/filings/0001437749-26-033713.md) |
| Operating income | $m | [(0.2) d](/filings/0001437749-25-004700.md) | [(0.4)](/filings/0001437749-25-013645.md) | [(0.2)](/filings/0001437749-25-023873.md) | [(0.3)](/filings/0001437749-25-033153.md) | [(0.4) d](/filings/0001437749-26-004876.md) | [(0.3)](/filings/0001437749-26-013744.md) | [(0.3)](/filings/0001437749-26-024770.md) | [(0.5)](/filings/0001437749-26-033713.md) | [(0.6) d](/filings/0001437749-26-004876.md) | [(0.5)](/filings/0001437749-26-013744.md) | [(0.6)](/filings/0001437749-26-024770.md) | [(0.3)](/filings/0001437749-26-033713.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1 d](/filings/0001437749-25-004700.md) | [0.0](/filings/0001437749-25-013645.md) | [0.1](/filings/0001437749-25-023873.md) | [0.1](/filings/0001437749-25-033153.md) | [(0.2) d](/filings/0001437749-26-004876.md) | [(0.0)](/filings/0001437749-26-013744.md) | [0.0](/filings/0001437749-26-024770.md) | [0.1](/filings/0001437749-26-033713.md) | [0.2 d](/filings/0001437749-26-004876.md) | [(0.0)](/filings/0001437749-26-013744.md) | [(0.0)](/filings/0001437749-26-024770.md) | [0.1](/filings/0001437749-26-033713.md) |
| Net income | $m | [0.4 d](/filings/0001437749-25-004700.md) | [0.2](/filings/0001437749-25-033153.md) | [0.2](/filings/0001437749-25-033153.md) | [0.0](/filings/0001437749-25-033153.md) | [0.2 d](/filings/0001437749-26-004876.md) | [0.1](/filings/0001437749-26-033713.md) | [0.0](/filings/0001437749-26-033713.md) | [(0.4)](/filings/0001437749-26-033713.md) | [(0.6) d](/filings/0001437749-26-004876.md) | [(0.2)](/filings/0001437749-26-033713.md) | [(0.5)](/filings/0001437749-26-033713.md) | [(0.2)](/filings/0001437749-26-033713.md) |
| Diluted EPS | $ per share | not reported | [0.02](/filings/0001437749-25-013645.md) | [0.02](/filings/0001437749-25-023873.md) | [0.00](/filings/0001437749-25-033153.md) | not reported | [0.01](/filings/0001437749-26-013744.md) | [0.00](/filings/0001437749-26-024770.md) | [(0.04)](/filings/0001437749-26-033713.md) | not reported | [(0.02)](/filings/0001437749-26-013744.md) | [(0.05)](/filings/0001437749-26-024770.md) | [(0.03)](/filings/0001437749-26-033713.md) |
| Basic EPS | $ per share | not reported | [0.02](/filings/0001437749-25-013645.md) | [0.02](/filings/0001437749-25-023873.md) | [0.00](/filings/0001437749-25-033153.md) | not reported | [0.01](/filings/0001437749-26-013744.md) | [0.00](/filings/0001437749-26-024770.md) | [(0.04)](/filings/0001437749-26-033713.md) | not reported | [(0.02)](/filings/0001437749-26-013744.md) | [(0.05)](/filings/0001437749-26-024770.md) | [(0.03)](/filings/0001437749-26-033713.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [56.2](/filings/0001437749-25-004700.md) | [25.8](/filings/0001437749-24-014082.md) | [15.6](/filings/0001437749-24-024000.md) | [22.9](/filings/0001437749-24-032546.md) | [13.5](/filings/0001437749-26-004876.md) | [21.7](/filings/0001437749-25-013645.md) | [10.5](/filings/0001437749-25-023873.md) | [14.3](/filings/0001437749-25-033153.md) | [6.8](/filings/0001437749-26-033713.md) | [9.2](/filings/0001437749-26-013744.md) | [9.5](/filings/0001437749-26-024770.md) | [5.8](/filings/0001437749-26-033713.md) |
| Current assets | $m | [64.2](/filings/0001437749-25-004700.md) | [62.7](/filings/0001437749-24-014082.md) | [56.9](/filings/0001437749-24-024000.md) | [53.8](/filings/0001437749-24-032546.md) | [51.0](/filings/0001437749-26-004876.md) | [48.8](/filings/0001437749-25-013645.md) | [40.9](/filings/0001437749-25-023873.md) | [37.9](/filings/0001437749-25-033153.md) | [34.2](/filings/0001437749-26-033713.md) | [26.5](/filings/0001437749-26-013744.md) | [23.7](/filings/0001437749-26-024770.md) | [22.0](/filings/0001437749-26-033713.md) |
| Total assets | $m | [69.1](/filings/0001437749-25-004700.md) | [67.6](/filings/0001437749-24-014082.md) | [61.5](/filings/0001437749-24-024000.md) | [58.3](/filings/0001437749-24-032546.md) | [55.4](/filings/0001437749-26-004876.md) | [53.2](/filings/0001437749-25-013645.md) | [45.2](/filings/0001437749-25-023873.md) | [42.3](/filings/0001437749-25-033153.md) | [38.4](/filings/0001437749-26-033713.md) | [32.0](/filings/0001437749-26-013744.md) | [29.2](/filings/0001437749-26-024770.md) | [27.3](/filings/0001437749-26-033713.md) |
| Current liabilities | $m | [20.0](/filings/0001437749-25-004700.md) | [20.9](/filings/0001437749-24-014082.md) | [22.1](/filings/0001437749-24-024000.md) | [21.1](/filings/0001437749-24-032546.md) | [20.8](/filings/0001437749-26-004876.md) | [20.7](/filings/0001437749-25-013645.md) | [14.9](/filings/0001437749-25-023873.md) | [14.8](/filings/0001437749-25-033153.md) | [13.7](/filings/0001437749-26-033713.md) | [13.2](/filings/0001437749-26-013744.md) | [11.9](/filings/0001437749-26-024770.md) | [10.3](/filings/0001437749-26-033713.md) |
| Total liabilities | $m | [27.5](/filings/0001437749-25-004700.md) | [28.3](/filings/0001437749-24-014082.md) | [24.2](/filings/0001437749-24-024000.md) | [23.0](/filings/0001437749-24-032546.md) | [22.5](/filings/0001437749-26-004876.md) | [22.3](/filings/0001437749-25-013645.md) | [16.3](/filings/0001437749-25-023873.md) | [16.1](/filings/0001437749-25-033153.md) | [15.0](/filings/0001437749-26-033713.md) | [15.5](/filings/0001437749-26-013744.md) | [14.0](/filings/0001437749-26-024770.md) | [12.3](/filings/0001437749-26-033713.md) |
| Shareholders' equity | $m | [41.6](/filings/0001437749-26-004876.md) | [39.4](/filings/0001437749-25-033153.md) | [37.3](/filings/0001437749-25-033153.md) | [35.3](/filings/0001437749-25-033153.md) | [32.9](/filings/0001437749-26-033713.md) | [30.9](/filings/0001437749-26-033713.md) | [28.9](/filings/0001437749-26-033713.md) | [26.1](/filings/0001437749-26-033713.md) | [23.4](/filings/0001437749-26-033713.md) | [16.5](/filings/0001437749-26-033713.md) | [15.2](/filings/0001437749-26-033713.md) | [15.0](/filings/0001437749-26-033713.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(69.0) d](/filings/0001437749-25-004700.md) | [549](/filings/0001437749-25-013645.md) | [(3,568) d](/filings/0001437749-25-023873.md) | [(436) d](/filings/0001437749-25-033153.md) | [88.0 d](/filings/0001437749-26-004876.md) | [484](/filings/0001437749-26-013744.md) | [(5,635) d](/filings/0001437749-26-024770.md) | [113 d](/filings/0001437749-26-033713.md) | [(959) d](/filings/0001437749-26-004876.md) | [(797)](/filings/0001437749-26-013744.md) | [(1,364) d](/filings/0001437749-26-024770.md) | [(1,092) d](/filings/0001437749-26-033713.md) |
| Capital expenditure | $k | [14.0 d](/filings/0001437749-25-004700.md) | [11.0](/filings/0001437749-25-013645.md) | [19.0 d](/filings/0001437749-25-023873.md) | [7.0 d](/filings/0001437749-25-033153.md) | [20.0 d](/filings/0001437749-26-004876.md) | [16.0](/filings/0001437749-26-013744.md) | [4.0 d](/filings/0001437749-26-024770.md) | [43.0 d](/filings/0001437749-26-033713.md) | [5.0 d](/filings/0001437749-26-004876.md) | [115](/filings/0001437749-26-013744.md) | [325 d](/filings/0001437749-26-024770.md) | [7.0 d](/filings/0001437749-26-033713.md) |
| Dividends paid | $k | [2,304 d](/filings/0001437749-25-004700.md) | [2,303](/filings/0001437749-25-013645.md) | [2,303 d](/filings/0001437749-25-023873.md) | [2,303 d](/filings/0001437749-25-033153.md) | [2,304 d](/filings/0001437749-26-004876.md) | [2,303](/filings/0001437749-26-013744.md) | [2,303 d](/filings/0001437749-26-024770.md) | [2,303 d](/filings/0001437749-26-033713.md) | [2,301 d](/filings/0001437749-26-004876.md) | [858](/filings/0001437749-26-013744.md) | [858 d](/filings/0001437749-26-024770.md) | [0.0 d](/filings/0001437749-26-033713.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001437749-26-013744.md) | [0.0 d](/filings/0001437749-26-024770.md) | [0.0 d](/filings/0001437749-26-033713.md) | not reported | [5,870](/filings/0001437749-26-013744.md) | [0.0 d](/filings/0001437749-26-024770.md) | [28.0 d](/filings/0001437749-26-033713.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.4](/filings/0001437749-24-014082.md) | [11.4](/filings/0001437749-24-024000.md) | [11.5](/filings/0001437749-24-032546.md) | [11.5](/filings/0001437749-25-013645.md) | [11.5](/filings/0001437749-25-023873.md) | [11.5](/filings/0001437749-25-033153.md) | [11.5](/filings/0001437749-26-013744.md) | [11.5](/filings/0001437749-26-024770.md) | [11.5](/filings/0001437749-26-033713.md) | [10.1](/filings/0001437749-26-013744.md) | [8.6](/filings/0001437749-26-024770.md) | [8.6](/filings/0001437749-26-033713.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,492,557 at 2026-10-23, from the cover of the [10-Q filed 2026-10-28](/filings/0001437749-26-033713.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 28, 2026, 09:27 ET. No prices; not investment advice.